No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Axilla
-
Brain Neoplasms / secondary
-
CCAAT-Enhancer-Binding Protein-beta / metabolism*
-
Disease Progression
-
Down-Regulation
-
Female
-
Gene Expression Regulation, Neoplastic
-
Groin
-
Histiocytic Sarcoma / diagnosis*
-
Histiocytic Sarcoma / etiology*
-
Histiocytic Sarcoma / metabolism
-
Histiocytic Sarcoma / pathology
-
Histiocytic Sarcoma / therapy
-
Humans
-
Hysterectomy
-
Immunohistochemistry
-
Immunophenotyping
-
Lymph Node Excision
-
Lymph Nodes / pathology*
-
Lymphoma, Mantle-Cell / complications*
-
Lymphoma, Mantle-Cell / diagnosis*
-
Lymphoma, Mantle-Cell / metabolism
-
Lymphoma, Mantle-Cell / pathology
-
Lymphoma, Mantle-Cell / therapy
-
Middle Aged
-
PAX5 Transcription Factor / metabolism*
-
Pelvic Neoplasms / secondary
-
Pelvic Neoplasms / therapy
-
Retroperitoneal Neoplasms / secondary
-
Retroperitoneal Neoplasms / therapy
-
Stem Cell Transplantation
-
Transplantation, Autologous
-
Transplantation, Homologous
-
Up-Regulation
-
Uterine Neoplasms / secondary
-
Uterine Neoplasms / therapy
Substances
-
CCAAT-Enhancer-Binding Protein-beta
-
PAX5 Transcription Factor
-
PAX5 protein, human